top of page
Blog
Featured Posts
Recent Posts
Archive
Follow Us
Search By Tags
Vraylar: A Diverse Tool for Mental Health
Introduction: Vraylar (cariprazine) was first approved by the FDA in 2015 to treat schizophrenia and bipolar disorder (Stewart, 2022)....
Auvelity: A New Treatment for Depression
Auvelity (Dextromethorphan HBr and Bupropion HCl) Auvelity is a new prescriptive agent that is the first of its kind. This medication is...
Mental Health: Maintenance vs. Intervention
The attention to mental health has increased in importance in recent years as more people are opening up about their struggles. 47...
Monoamine Oxidase Inhibitors: An Old-School Treatment Option for Depression
Brief Overview Just like SSRIs are considered a “class of antidepressants,” MAOIs, or Monoamine Oxidase Inhibitors, are in a class of...
Alternative Applications for Tricyclic Antidepressants
Tricyclic medications were first introduced in 1957 for the treatment of depression. Imipramine was the first tricyclic medication shown...
bottom of page